Community-Informed Interventions for Equitable Congestive Heart Failure Management in Primary Care
for Congestive Heart Failure
1 location in Rochester
Sponsor: Mayo Clinic
Sex: All·Age: 18+
Code: NCT07730827·Recruiting·Listed Jul 28, 2026
Paid Clinical Trials in Rochester, MN
As of July 2026, 1,196 paid clinical trials are recruiting in Rochester, Minnesota. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Rochester offers studies at sites including Mayo Clinic for conditions such as Malignant Solid Neoplasm, Heart Failure, Ovarian Cancer, Breast Cancer. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Rochester
Trials by drug in Rochester
Filter results
Filter results
Newly added in Rochester
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
DRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization (PVE/HVE) to Increase Future Liver Remnant Before Resection.
for Liver Cancer
Sites in Rochester +2 more locations
Sponsor: Maastricht University Medical Center
Sex: All·Age: 18+
Code: NCT07717437·Recruiting·Listed Jul 21, 2026
Acute Kidney Injury In Care Transitions (ACT): Pragmatic Clinical Trial
for Acute Kidney Injury
Sites in Rochester, Mankato +1 more location
Sponsor: Mayo Clinic
Sex: All·Age: 18+
Code: NCT07670520·Recruiting·Listed Jun 26, 2026
Virtual Group Resilient Living Program For Patients Living With Advanced Cancer
for Advanced Cancer
1 location in Rochester
Sponsor: Mayo Clinic
Sex: All·Age: 18+
Code: NCT07659158·Recruiting·Listed Jun 22, 2026
COMPARE-VENT Feasibility Pilot Study
for Respiration Failure
1 location in Rochester
Sponsor: Mayo Clinic
Sex: All·Age: 18+
Code: NCT07656259·Recruiting·Listed Jun 18, 2026
AAVrh10-PCCA Gene Therapy for Propionic Acidemia
for Propionic Acidemia
1 location in Rochester
Sponsor: Mayo Clinic
Sex: All·Age: 6 Months - 2
Code: NCT07643844·Phase 1·Recruiting·Listed Jun 12, 2026
1,014 clinical trials
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
for Cognitive Dysfunction
Drug: Donanemab
Sites in Rochester, Golden Valley +40 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 55 - 85
Code: NCT07589595·Phase 2·Recruiting·Listed May 2026
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
for Ulcerative Colitis (UC)
Drug: LY4268989
Sites in Rochester +49 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18 - 80
Code: NCT07415044·Phase 2·Recruiting·Listed Feb 2026
A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- Associated Steatohepatitis (MASH)
for Liver Cirrhosis
Drug: BI 3802876
Sites in Rochester +25 more locations
Sponsor: Boehringer Ingelheim
Sex: All·Age: 18 - 75
Code: NCT07325526·Phase 2·Recruiting·Listed Jan 2026
Parasternal Extravascular ICD System Pivotal Clinical Investigation (ALARION EV) Study
for Ventricular Arrythmia
Sites in Rochester +26 more locations
Sponsor: AtaCor Medical, Inc.
Sex: All·Age: 18+
Code: NCT07324031·Recruiting·Listed Jan 2026
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
for Carcinoma, Renal Cell
Drug: PF-08634404
Sites in Rochester, Burnsville +107 more locations
Sponsor: Pfizer
Sex: All·Age: 18+
Code: NCT07227415·Phase 1, Phase 2·Recruiting·Listed Nov 2025
Study of DONQ52 in Active Celiac Disease
for Celiac Disease
Drug: DONQ52
Sites in Rochester +54 more locations
Sponsor: Chugai Pharmaceutical
Sex: All·Age: 18 - 75
Code: NCT07239336·Phase 2·Recruiting·Listed Nov 2025
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
for Pancreatic Cancer
Drug: daraxonrasib
Sites in Rochester +28 more locations
Sponsor: Revolution Medicines, Inc.
Sex: All·Age: 18+
Code: NCT07252232·Phase 3·Recruiting·Listed Nov 2025
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
for Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma
Drug: Nivolumab
Sites in Rochester +33 more locations
Sponsor: Bristol-Myers Squibb
Sex: All·Age: 18+
Code: NCT07221149·Phase 2, Phase 3·Recruiting·Listed Oct 2025
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
for Breast Neoplasms
Sites in Rochester, Minneapolis +116 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07174336·Phase 3·Recruiting·Listed Sep 2025
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
for Ovarian Neoplasms
Sites in Rochester +87 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07213804·Phase 3·Recruiting·Listed Oct 2025
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
for Transthyretin Amyloid Cardiomyopathy (ATTR CM)
Drug: Coramitug
Sites in Rochester +59 more locations
Sponsor: Novo Nordisk A/S
Sex: All·Age: 18+
Code: NCT07207811·Phase 3·Recruiting·Listed Oct 2025
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
for Cardiovascular Disease
Drug: Olpasiran
Sites in Rochester, Maplewood +199 more locations
Sponsor: Amgen
Sex: All·Age: 50 - 105
Code: NCT07136012·Phase 3·Recruiting·Listed Aug 2025
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
for Crohn Disease
Sites in Rochester +54 more locations
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT07196722·Phase 2, Phase 3·Recruiting·Listed Sep 2025
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
for Colorectal Neoplasms
Sites in Rochester, Burnsville +106 more locations
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Sex: All·Age: 18+
Code: NCT05253651·Phase 3·Recruiting·Listed Feb 2022
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
for Large B-cell Lymphoma
Sites in Rochester +36 more locations
Sponsor: Lyell Immunopharma, Inc.
Sex: All·Age: 18+
Code: NCT07188558·Phase 3·Recruiting·Listed Sep 2025
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
for Triple Negative Breast Cancer
Sites in Rochester, Maplewood +122 more locations
Sponsor: Gilead Sciences
Sex: All·Age: 18+
Code: NCT05633654·Phase 3·Recruiting·Listed Dec 2022
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
for Chronic Obstructive Pulmonary Disease
Drug: Lunsekimig
Sites in Rochester +65 more locations
Sponsor: Sanofi
Sex: All·Age: 40 - 80
Code: NCT07190209·Phase 3·Recruiting·Listed Sep 2025
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
for Pediatric Migraine
Sites in Rochester +80 more locations
Sponsor: Pfizer
Sex: All·Age: 6 - 17
Code: NCT04649242·Phase 3·Recruiting·Listed Dec 2020
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
for Breast Cancer
Sites in Rochester, Mankato +167 more locations
Sponsor: Stemline Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT06492616·Phase 3·Recruiting·Listed Jul 2024
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
for Carcinoma, Non-Small-Cell Lung
Drug: Amivantamab
Sites in Rochester, Minneapolis +127 more locations
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT06667076·Phase 2·Recruiting·Listed Oct 2024
A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes
for Diabetes Mellitus, Type 1
Sites in Rochester +43 more locations
Sponsor: Novo Nordisk A/S
Sex: All·Age: 18+
Code: NCT07076199·Phase 3·Recruiting·Listed Jul 2025
Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors
for Renal Cell Carcinoma (RCC)
Sites in Rochester +43 more locations
Sponsor: Exelixis
Sex: All·Age: 18+
Code: NCT05176483·Phase 1·Recruiting·Listed Jan 2022
A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)
for Small-cell Lung Cancer
Drug: Durvalumab
Sites in Rochester, Edina +48 more locations
Sponsor: Amgen
Sex: All·Age: 18 - 99
Code: NCT07005128·Phase 3·Recruiting·Listed Jun 2025
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
for Heart Failure
Drug: Empagliflozin
Sites in Rochester, Saint Paul +97 more locations
Sponsor: Boehringer Ingelheim
Sex: All·Age: 18+
Code: NCT06935370·Phase 3·Recruiting·Listed Apr 2025
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
for Advanced Cancer
Sites in Rochester, Maple Grove +36 more locations
Sponsor: Artios Pharma Ltd
Sex: All·Age: 18+
Code: NCT04657068·Phase 1, Phase 2·Recruiting·Listed Dec 2020
Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)
for Neovascular Age-related Macular Degeneration
Drug: Surabgene Lomparvovec
Sites in Rochester, Edina +49 more locations
Sponsor: AbbVie
Sex: All·Age: 50+
Code: NCT07007065·Phase 3·Recruiting·Listed Jun 2025
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
for Crohn's Disease
Drug: Tulisokibart
Sites in Rochester +70 more locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 16 - 80
Code: NCT06430801·Phase 3·Recruiting·Listed May 2024
A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines
for Chronic Spontaneous Urticaria (CSU)
Drug: Remibrutinib
Sites in Rochester, Minneapolis +126 more locations
Sponsor: Novartis Pharmaceuticals
Sex: All·Age: 18+
Code: NCT06868212·Phase 3·Recruiting·Listed Mar 2025
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
for Neoplasms
Sites in Rochester, Minneapolis +76 more locations
Sponsor: Celgene
Sex: All·Age: All ages
Code: NCT03435796·Phase 2, Phase 3·Recruiting·Listed Feb 2018
A Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
for Chronic Lymphocytic Leukemia
Sites in Rochester +41 more locations
Sponsor: BeOne Medicines
Sex: All·Age: 18+
Code: NCT06973187·Phase 3·Recruiting·Listed May 2025
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
for Lumbar Spinal Stenosis
Sites in Rochester, Burnsville +2341 more locations
Sponsor: Stryker Instruments
Sex: All·Age: 18+
Code: NCT03072927·Recruiting·Listed Mar 2017
Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study
for Moderate Aortic Valve Stenosis
Drug: Ataciguat
Sites in Rochester, Maplewood +67 more locations
Sponsor: Kardigan, Inc.
Sex: All·Age: 50+
Code: NCT07001800·Phase 2, Phase 3·Recruiting·Listed Jun 2025
Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard Available Therapies in Adult Participants With Relapsed or Refractory Multiple Myeloma
for Multiple Myeloma
Drug: Etentamig
Sites in Rochester +34 more locations
Sponsor: AbbVie
Sex: All·Age: 18+
Code: NCT06158841·Phase 3·Recruiting·Listed Dec 2023
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
for Metastatic Colorectal Cancer
Sites in Rochester +19 more locations
Sponsor: Hoffmann-La Roche
Sex: All·Age: 18+
Code: NCT04929223·Phase 1·Recruiting·Listed Jun 2021
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
for Primary Biliary Cholangitis
Sites in Rochester +50 more locations
Sponsor: Gilead Sciences
Sex: All·Age: 18+
Code: NCT06051617·Phase 3·Recruiting·Listed Sep 2023
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
for Cachexia
Drug: ponsegromab
Sites in Rochester +80 more locations
Sponsor: Pfizer
Sex: All·Age: 18+
Code: NCT06989437·Phase 2, Phase 3·Recruiting·Listed May 2025
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
for Chronic Lymphocytic Leukemia
Drug: Sonrotoclax
Sites in Rochester +37 more locations
Sponsor: BeOne Medicines
Sex: All·Age: 18+
Code: NCT06943872·Phase 3·Recruiting·Listed Apr 2025
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
for Mantle Cell Lymphoma
Drug: Sonrotoclax
Sites in Rochester +40 more locations
Sponsor: BeOne Medicines
Sex: All·Age: 18+
Code: NCT06742996·Phase 3·Recruiting·Listed Dec 2024
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
for Breast Neoplasms
Sites in Rochester +38 more locations
Sponsor: Natera, Inc.
Sex: All·Age: 18+
Code: NCT07214532·Recruiting·Listed Oct 2025
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
for Pancreatic Neuroendocrine Tumor (pNET)
Sites in Rochester +39 more locations
Sponsor: Exelixis
Sex: All·Age: 18+
Code: NCT06943755·Phase 2, Phase 3·Recruiting·Listed Apr 2025
Top Research Study Locations in Rochester
Researchers run research studies in Rochester, MN at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Mayo Clinic | Heart Failure, Breast Cancer, Cardiovascular Diseases | 455 |
| Mayo Clinic in Rochester | Malignant Solid Neoplasm, Hematopoietic and Lymphatic System Neoplasm, Breast Carcinoma | 401 |
| Mayo Clinic Rochester | CRC, Chronic Lymphocytic Leukemia, Colorectal Cancer | 73 |
| Mayo Clinic - Rochester | Endometrial Cancer, Epilepsy, Epilepsy (Treatment Refractory) | 29 |
| Mayo Clinic Minnesota | Healthy, Advanced Melanoma, Aging | 28 |
| Mayo Clinic in Rochester, Minnesota | Multiple Myeloma, Neoplasm Metastasis, Amyloid | 13 |
| Mayo Clinic, Rochester | Interstitial Lung Diseases, Acute Kidney Failure, Acute Kidney Insufficiency | 10 |
| Mayo Clinic Cancer Center | Lung Cancer, PDAC, PDAC - Pancreatic Ductal Adenocarcinoma | 7 |
| Mayo Clinic in Minnesota | Advanced Solid Tumor, Bladder Spasms, Colorectal Cancer (CRC) | 6 |
| Clinical Trial Site | Advanced Hepatocellular Carcinoma, End Stage Renal Disease, Hereditary Transthyretin-Mediated Amyloidosis With Polyneuropathy | 5 |
| Mayo Clinic (Data Collection Only) | Adult T-cell Leukemia/Lymphoma, Aggressive NK-cell Leukemia, Anaplastic Large Cell Lymphoma, ALK-Positive | 4 |
| Mayo Clinic - PIN | Crohn's Disease (CD), Developmental and Epileptic Encephalopathy, Dravet Syndrome | 4 |
| GSK Investigational Site | Amyloidosis, Gastrointestinal Neoplasms, Neoplasms, Prostate | 3 |
| Mayo Clinic - PPDS | Alpha1-Antitrypsin Deficiency, Metastatic HER2-positive Breast Cancer, Uveal Melanoma | 3 |
| Mayo Clinic Cancer Center Outpatient Pharmacy | Advanced Renal Cell Carcinoma, Advanced or Metastatic Renal Cell Carcinoma, Cachexia | 3 |
| Mayo Clinic Comprehensive Cancer Center | Acute Myeloid Leukemia, Advanced Or Metastatic Merkel Cell Carcinoma, Clear Cell Renal Cell Carcinoma (ccRCC) | 3 |
| Mayo Clinic Hospital | ADA SCID, Glioblastoma, Glioblastoma (GBM) | 3 |
| Mayo Clinic- Rochester | Aneurysmal Subarachnoid Hemorrhage (aSAH), Cerebral Vasospasm, Crohns Disease | 3 |
| Mayo Clinic - Rochester | Multiple Myeloma, Immunoglobulin Light Chain (AL) Amyloidosis | 3 |
| 89bio Clinical Study Site | Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis, Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis | 2 |
| Crinetics Study Site | Classic Congenital Adrenal Hyperplasia, Congenital Adrenal Hyperplasia, Neuroendocrine Neoplasm | 2 |
| Mayo Clinic - Rochester Minnesota | Intermediate Risk Non-Muscle Invasive Bladder Cancer, Low-grade Upper Tract Urothelial Carcinoma | 2 |
| Mayo Clinic Department of Ophthalmology | Amblyopia | 2 |
| Mayo Clinic Foundation | Orthostatic Hypotension, Reflex Syncope, Weight Loss | 2 |
| Mayo Clinic Saint Marys Campus | Intracerebral Hemorrhage, Stroke, Stroke, Acute | 2 |
Active & Upcoming Studies in Rochester (2026)
Recruiting trials in Rochester grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (365 active studies)
Cardiovascular (91 active studies)
- Fetal Aortic Valvuloplasty for Evolving Hypoplastic Left Heart Syndrome · Mauro H. Schenone
- MCG In Long QT Syndrome · Mayo Clinic
Neurology & pain (69 active studies)
- The Effect of Dry Needling With Electrical Stimulation on Individuals With Restless Legs Syndrome · Mayo Clinic
- A Study Of Synthetic THC And Sleep · Phase 2, Phase 3 · Mayo Clinic
Diabetes & metabolic (34 active studies)
Mental health & behavior (13 active studies)
- A Study Of Senyo Health With Comorbid Alcohol Use Disorder Treatment In Bipolar Patients · Mayo Clinic
- A Study Of Vagal Nerve Stimulation In Conjunction With NRT For Smoking Cessation · Phase 2, Phase 3 · Mayo Clinic
Pediatric (8 active studies)
- Predicting the Need for Prolonged Respiratory Support in Neonates Delivered in a Lower-Level NICU Setting · Mayo Clinic
- Supraglottic Airway for Resuscitation Trial · Children's Hospital of Philadelphia
Vaccines (6 active studies)
Eye & vision (5 active studies)
- 24-hour Effect of Rocklatan Compared With Latanoprost in Open Angle Glaucoma and Ocular Hypertension Patients · Phase 4 · Mayo Clinic
- Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD) · Phase 3 · AbbVie
HIV / STI (2 active studies)
- Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States · Phase 2 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Analytic Treatment Interruption (ATI) to Assess HIV Cure · Mayo Clinic
Common conditions studied in Rochester
- Malignant Solid Neoplasm (19 active studies)
- Heart Failure (16 active studies)
- Ovarian Cancer (15 active studies)
- Breast Cancer (14 active studies)
- Healthy (14 active studies)
- Hematopoietic and Lymphatic System Neoplasm (13 active studies)
Leading research sponsors in Rochester
- Mayo Clinic
- AstraZeneca
- National Cancer Institute (NCI)
- Children's Oncology Group
- Eli Lilly and Company
Frequently asked questions
How many paid clinical trials are currently recruiting in Rochester?
There are approximately 1,196 recruiting clinical trials in Rochester, Minnesota listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Rochester pay participants?
Most recruiting trials in Rochester compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Rochester?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Rochester?
The most common conditions under active study in Rochester include Malignant Solid Neoplasm (19), Heart Failure (16), Ovarian Cancer (15), Breast Cancer (14), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Rochester?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Rochester on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Rochester?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Rochester?
Recruiting research sites in Rochester include Mayo Clinic, Mayo Clinic in Rochester, Mayo Clinic Rochester, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Rochester right now?
The largest active categories in Rochester are Cancer & tumors (365), Cardiovascular (91), Neurology & pain (69). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
Browse more clinical trials
Other cities in Minnesota
Minneapolis, MN(906)Saint Paul, MN(173)Saint Louis Park, MN(125)Edina, MN(118)Coon Rapids, MN(114)Duluth, MN(101)Maplewood, MN(88)Woodbury, MN(71)Burnsville, MN(70)Deer River, MN(69)Virginia, MN(69)Hibbing, MN(68)Maple Grove, MN(68)Sandstone, MN(67)Bemidji, MN(62)Saint Cloud, MN(57)Brainerd, MN(56)Robbinsdale, MN(52)Waconia, MN(52)Shakopee, MN(50)Stillwater, MN(48)Willmar, MN(43)Monticello, MN(42)New Ulm, MN(39)Princeton, MN(36)Wyoming, MN(35)Mankato, MN(32)Detroit Lakes, MN(29)Chaska, MN(27)Fosston, MN(26)Park Rapids, MN(25)Cambridge, MN(24)Worthington, MN(23)Ely, MN(21)International Falls, MN(21)Moose Lake, MN(21)Thief River Falls, MN(21)Aitkin, MN(20)Baxter, MN(20)Crosslake, MN(17)Pequot Lakes, MN(17)Pine River, MN(17)Staples, MN(17)Albert Lea, MN(15)New Brighton, MN(11)Bloomington, MN(9)Alexandria, MN(7)Fridley, MN(7)Marshall, MN(7)Plymouth, MN(6)Minneota, MN(5)Richfield, MN(5)Eagan, MN(4)Golden Valley, MN(4)Medina, MN(4)Minnetonka, MN(4)Roseville, MN(4)Sartell, MN(4)Dilworth, MN(3)Eden Prairie, MN(3)